Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational Survey.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 13 2 2020
medline: 23 6 2021
entrez: 13 2 2020
Statut: ppublish

Résumé

Burnout is defined as a three-dimensional syndrome-emotional exhaustion (EE), depersonalization (DP), and reduced personal accomplishment (PA)-caused by chronic occupational stress. The aim of the current study was to investigate the prevalence of burnout among oncologists in Eastern Europe and to identify the contributing factors. The study was conducted as an online survey between October 2017 and March 2018. Oncologists (including medical, radiation, clinical, and surgical oncologists) from 19 countries were invited to participate. The survey consisted of 30 questions, including the standardized burnout instrument, Maslach Burnout Inventory, and eight demographic questions. Burnout risk was scored according to the scoring manual for health care workers. The study included 637 oncologists. Overall, 28% were at low or intermediate risk and 72% were at high risk for burnout. Forty-four percent of participants were at high risk for EE, 28.7% for DP, and 47.3% for PA. EE risk was associated with female sex. DP risk was highest among clinical and radiation oncologists, whereas PA risk was positively correlated with years of service, percentage of cancer deaths, and availability of the number of oncologists. In multivariate logistic regression analysis, burnout was significantly associated with standardized cancer mortality and fewer years of practice. Burnout among oncologists in Eastern Europe is high, and younger oncologists are the most vulnerable group. Preventive measures should be taken to address this issue, which negatively affects optimal care delivery and poses a threat to oncologists' health and well-being.

Identifiants

pubmed: 32048930
doi: 10.1200/JOP.19.00470
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e366-e376

Auteurs

Davor Kust (D)

Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.

Jure Murgic (J)

Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.

Petra Vukovic (P)

Department of Medical Oncology, University Hospital for Tumors, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.

Ivan Kruljac (I)

Department of Internal Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.

Marin Prpic (M)

Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Ana Zilic (A)

Intensive Oncology and Supportive Care Department, Clinic For Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.

Csongor Lengyel (C)

Acratus, Budapest, Hungary.

Kamil Wdowiak (K)

Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Katowice, Poland.

Lina Simaskaite (L)

Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.

Ulug Mutlu Gunaydin (U)

Department of Medical Oncology, Istanbul Medeniyet University, Istanbul, Turkey.

Ivana Tica Sedlar (I)

Clinic of Oncology, University Hospital Mostar, Mostar, Bosnia and Herzegovina.

Elena Fountzilas (E)

Department of Medical Oncology, Euromedica General Clinic, Thessaloniki, Greece.

Urska Janzic (U)

Medical Oncology Unit, University Clinic Golnik, Golnik, Slovenia.

Iulia Coroian (I)

Medical Oncology Department, Oncology Institute Prof. Dr. I. Chiricuta, Cluj-Napoca, Romania.

Ivana Durutovic (I)

Clinic for Oncology and Radiotherapy, Clinical Center of Montenegro, Podgorica, Montenegro.

Benedetta Pellegrino (B)

Department of Medical Oncology, University Hospital of Parma, Parma, Italy.

Mila Petrova (M)

Department of Medical Oncology, Multi Profile Hospital for Active Treatment Nadezhda, Sofia, Bulgaria.

Emiljana Huti (E)

Department of Oncology, American Hospital Tirana II, Tirana, Albania.

Elena Napolskaia (E)

Outpatient Department, Clinical Scientifical Practical Center of Specialized Kinds of Medical Care (Oncology), Saint Petersburg, Russia.

Bostjan Seruga (B)

Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Antonija Balenovic (A)

Health Center "Zagreb Centar," Zagreb, Croatia.

Ana Frobe (A)

Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Kresimir Luetic (K)

Department of Gastroenterology and Hepatology, Clinical Hospital "Sveti Duh," Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH